A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease
Clinical trial NCT00890890 · TERMINATED
Trial details
- NCT number
- NCT00890890
- Sponsor
- Bristol-Myers Squibb
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-05-01
- Primary completion
- 2013-07-01
- Enrollment
- 263
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.